Year 2015
|
|
07.10.2015
|
SEMICON Europa
2014 (October 7-9 2014), Grenoble, France
|
19.10.2015
|
EMT Summit, San Francisco Bay, CA
|
30.06.2015
|
Wearable Tech + Digital Health NYC, New York
|
30.06.2015
|
HTS Health Tech Summit, Lausanne
|
01.03.2015
|
Investments,
Zug, Malaga, Edinburgh
|
Year 2014
|
|
30.11.2014
|
Launch DnBiolab, Malaga, Spain
|
07.11.2014
|
EMERGING MedicalTechnologies Summit, San Francisco Bay,
November 11-12, 2014, USA
|
03.11.2014
|
BIO-Europe is Europe's largest partnering conference serving the globalBiotechnology industry 2014
|
09.10.2014
|
ENTENTE Life-Sciences-Investment Forum will take place in Brussels October 9, 2014 Belgium
|
07.10.2014
|
SEMICON Europa
2014 (October 7-9 2014), Grenoble, France
|
24.09.2014
|
BIOPHARM America
2014 Boston, MA, USA
|
23.09.2014
|
European Food Venture Forum September 23724 2014
|
23.06.2014
|
HTS Healthtech Summit will return to Lausanne on June 23&24, 2014
|
27.05.2014
|
MOBIP Pan European Partnership and
Investment for Mobile Services, Thessaloniki, Grece
|
22.05.2014
|
32 Technology companies selected to showcase at VENTURE4i,
Grenoble-Alpes - 22 May 2014, France
|
27.02.2014
|
EMMINVEST
European enterpreneurship promotional program, Berlin, Germany
|
Year 2013
|
|
15.10.2013
|
Launch DnBiomed,
Spain
|
05.02.2013
|
Sales preparations USA, Begin 1st September 2013
|
01.02.2013
|
Indiegogo, CA,
USA
|
Year 2012
|
|
10.11.2012
|
2nd Study & FDA (July 2012) / CE (August 2010) clearance
„clinical-trials.gov; ...A Networked System for Self-Management.... Editable
sensor for electronically confirming adherence to oral medications; 21 CFR
880.6305
|
24.10.2012
|
EVC Aarhus, Semi-Final European Venture Contest, HealthCare,
presentation, Aarhus, DK
|
25.09.2012
|
World Medtech Forum, Lucerne, CH
|
20.09.2012
|
Bio-Spain 2012, Meeting Biotechnology, presentation, Bilbao, ES
|
04.07.2012
|
SEF-Swiss Start-Up Award, Zurich
|
20.03.2012
|
MedTech Investing
Europe Conference, Montreux
|
19.03.2012
|
3rd pat.pend. preceded by the 1st CH684982 patent; 2nd
CH706255 (A2); PCT-WO2012-xxxxxxxxx pat.pend.
|
01.01.2012
|
Sale activities: third party sale, maximiseBE sales
efforts.
|
Year 2011
|
|
21.11.2011
|
1st Study & FDA clearance „clinical-trials.gov; NCT00407420
(Bristol Royal Hospital,UK)/ (Dr. Per Sodersten, PhD, Karolinska Institutet,
Stockholm; FDA clearance http://www.mando.se/_uploads/_documents/News/Mandometer_Approved_By_FDA.pdf; New York, N.Y., April 6, 2011; "proof of concept"
|
29.09.2011
|
Business competition Switzerland "Venture.ch", ETHZ/McKinsey
|
17.08.2011
|
Internet presence
|
07.07.2011
|
Workshop EUResearch about Clinical Trial
|
30.06.2011
|
Business competition Austria "AdventurX (place < 10)"
|
30.06.2011
|
Business competition Germany "Science4Life (place < 20)"
|
31.05.2011
|
MedTech Investing Europe Conference, and EPFL, Lausanne, as well as in
London, GB / HongKong
|
Year 2010
|
|
01.11.2010
|
Venturelab 2010 planning and training stages
|
20.06.2010
|
Marketing and PR concept created by Partner Company, May / June 2010
|
15.06.2010
|
As of day we have 10 fully functional products available which
are in test use since June 2010
|
01.03.2010
|
Foundation of
Erib Ltd.
|
Year 2009
|
|
01.06.2009
|
Project design, implementation and final stages of
development and prototypes have been completed
|
15.05.2009
|
2nd pat.pend. preceded by the 1st CH684982 patent;
CH701039 (A2); PCT-WO2009-xxxxxxxxx pat.pend.
|
Year 2008
|
|
01.01.2008
|
Start and
business disposition of "Erib Corp"
|
|
|